Pdt Partners, LLC Karuna Therapeutics, Inc. Transaction History

Pdt Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$123.79 - $277.42 $259,216 - $580,917	2,094 New	2,094 $471,000
Q4 2021 Feb 14, 2022	SELL	$110.64 - $159.4 $707,100 - $1.02 Million	-6,391 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$101.2 - $125.87 $1.4 Million - $1.74 Million	-13,809 Reduced 68.36%	6,391 $782,000
Q2 2021 Aug 16, 2021	BUY	$107.45 - $135.95 $1.52 Million - $1.93 Million	14,186 Added 235.88%	20,200 $2.3 Million
Q1 2021 May 17, 2021	BUY	$95.46 - $133.08 $574,096 - $800,343	6,014 New	6,014 $723,000

332K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Pdt Partners, LLC with notifications on news.